In the assessment of 12-month price targets, analysts unveil insights for CoreWeave, presenting an average target of $151.73, ...

Intellia Therapeutics (NASDAQ: NTLA) underwent analysis by 21 analysts in the last quarter, revealing a spectrum of ...

Madrigal Pharmaceuticals (MDGL) announced positive two-year data from the open-label compensated MASH cirrhosis arm of the Phase 3 MAESTRO-NAFLD-1 ...

Q3 2025 Earnings Call November 10, 2025 5:00 PM ESTCompany ParticipantsRaymond JonesLauren Antonoff - CEO & DirectorChris Hulls ...

Thank you. Good afternoon, and welcome to Viant Technologies Third Quarter 2025 Earnings Conference Call. On the call today are Tim Vanderhook, Co-Founder and Chief Executive Officer; Chris Vanderhook ...